Yale Wang
Abbott Northwestern Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yale Wang.
Archive | 2018
Judit Karacsonyi; Anil Poulose; Ivan Chavez; Yale Wang; Imre Ungi; Subhash Banerjee; Emmanouil S. Brilakis
Saphenous vein graft (SVG) percutaneous coronary interventions (PCIs) are common, currently representing approximately 6% of the overall PCI volume. SVG PCI is associated with higher risk of periprocedural complications and lower long-term patency compared with native coronary artery PCI; hence, the latter is preferred to SVG PCI whenever possible. Embolic protection devices and intragraft vasodilator administration can help to reduce the risk or consequences of distal embolization; however, they are currently underutilized. Drug-eluting stents can reduce the risk of in-stent restenosis and the need for repeat revascularization as compared with bare-metal stents in SVG lesions.
Journal of Interventional Cardiology | 2018
Michael Megaly; Marwan Saad; Peter Tajti; M. Nicholas Burke; Ivan Chavez; Mario Gössl; Daniel Lips; Michael Mooney; Anil Poulose; Paul Sorajja; Jay H. Traverse; Yale Wang; Louis P. Kohl; Steven M. Bradley; Emmanouil S. Brilakis
BACKGROUND We sought to examine the impact of coronary chronic total occlusion (CTO) percutaneous coronary intervention (PCI) on left ventricular (LV) function. METHODS We performed a systematic review and meta-analysis of studies published between January 1980 and November 2017 on the impact of successful CTO PCI on LV function. RESULTS A total of 34 observational studies including 2735 patients were included in the meta-analysis. Over a weighted mean follow-up of 7.9 months, successful CTO PCI was associated with an increase in LV ejection fraction by 3.8% (95%CI 3.0-4.7, P < 0.0001, I2 = 45%). In secondary analysis of 15 studies (1248 patients) that defined CTOs as occlusions of at least 3-month duration and reported follow-up of at least 3-months after the procedure, successful CTO PCI was associated with improvement in LV ejection fraction by 4.3% (95%CI [3.1, 5.6], P < 0.0001). In the 10 studies (502 patients) that reported LV end-systolic volume, successful CTO PCI was associated with a decrease in LV end-systolic volume by 4 mL, (95%CI -6.0 to -2.1, P < 0.0001, I2 = 0%). LV end-diastolic volume was reported in 9 studies with 403 patients and did not significantly change after successful CTO PCI (-2.3 mL, 95%CI -5.7 to 1.2 mL, P = 0.19, I2 = 0%). CONCLUSIONS Successful CTO PCI is associated with a statistically significant improvement in LV ejection fraction and decrease in LV end-systolic volume, that may reflect a beneficial effect of CTO recanalization on LV remodeling. The clinical implications of these findings warrant further investigation.
Expert Review of Cardiovascular Therapy | 2018
Peter Tajti; Iosif Xenogiannis; Ivan Chavez; Mario Gössl; Michael Mooney; Anil Poulose; Paul Sorajja; Jay H. Traverse; Yale Wang; M. Nicholas Burke; Emmanouil S. Brilakis
ABSTRACT Introduction: Coronary artery perforations are more likely to occur during percutaneous coronary intervention of complex coronary lesions, such as heavily calcified lesions and chronic total occlusions. Areas covered: Authors provide an update on the management of coronary perforations by performing a critical review of the related, recently published literature. Expert commentary: Meticulous attention to guidewire position and to device selection is critical for minimizing the risk for coronary perforation. If a perforation occurs, following a structured, algorithmic approach can maximize the likelihood of a successful outcome.
Catheterization and Cardiovascular Interventions | 2018
Ann Iverson; Larissa Stanberry; Ross Garberich; Amber Antos; Yader Sandoval; M. Nicholas Burke; Ivan Chavez; Mario Gössl; Timothy D. Henry; Daniel Lips; Michael Mooney; Anil Poulose; Paul Sorajja; Jay H. Traverse; Yale Wang; Steven M. Bradley; Emmanouil S. Brilakis
This study sought to compare the clinical outcomes of percutaneous coronary interventions (PCIs) performed by sleep deprived and non‐sleep deprived operators.
Cardiovascular Revascularization Medicine | 2018
Ann Iverson; Larissa Stanberry; Peter Tajti; Ross Garberich; Amber Antos; M. Nicholas Burke; Ivan Chavez; Mario Gössl; Timothy D. Henry; Daniel Lips; Michael Mooney; Anil Poulose; Paul Sorajja; Jay H. Traverse; Yale Wang; Steven M. Bradley; Emmanouil S. Brilakis
BACKGROUND/PURPOSE Patients and lesions at a higher procedural risk for percutaneous coronary intervention (PCI) are an understudied population. We examined the frequency, clinical characteristics, and outcomes of higher risk and non-higher risk PCIs at a large tertiary center. METHODS/MATERIALS The following procedures were considered higher risk: unprotected left main PCI, chronic total occlusion PCI, PCI requiring atherectomy, multivessel PCI, bifurcation PCI, PCI in prior coronary artery bypass graft surgery (CABG) patients, pre-PCI left ventricular ejection fraction ≤30%, or use of hemodynamic support. RESULTS Of the 1975 PCIs performed from 6/29/09 to 12/30/2016 in patients without acute coronary syndromes, 1230 (62%) were higher risk. Patients undergoing higher risk PCI were more likely to have a history of CABG, myocardial infarction, PCI, cerebrovascular disease, peripheral arterial disease, or congestive heart failure. Higher risk PCIs required more stents (2.0 vs. 1.0, p < 0.001), and had longer median fluoroscopy times (17.3 vs. 8.5 min, p < 0.001) and higher median contrast doses (160 vs. 120 mL, p < 0.001). In higher risk PCIs, the risks for technical failure and periprocedural complications were 2.9 (95% CI 1.2-7.4) times and 2.2 (95% CI 0.9-5.4) times higher as compared with non-higher risk PCI procedures. CONCLUSIONS In summary, over half of the PCIs performed in non-acute coronary syndrome patients were higher risk and were associated with lower odds of technical success and higher periprocedural complication rates as compared with non-higher risk PCIs. SUMMARY We examined the frequency, clinical characteristics, and outcomes of higher risk and non-higher risk PCIs at a large tertiary center. Higher risk PCI was associated with lower odds of technical and procedural success and higher odds of procedural complications as compared with non-higher risk PCI. However, the risk/benefit ratio may still be favorable for many of these higher-risk patients and should be estimated on a case by case basis.
Jacc-cardiovascular Interventions | 2017
Yader Sandoval; M. Nicholas Burke; Angie S. Lobo; Daniel Lips; Arnold H. Seto; Ivan Chavez; Paul Sorajja; Mazen Abu-Fadel; Yale Wang; Anil Poulouse; Mario Gössl; Michael Mooney; Jay H. Traverse; David Tierney; Emmanouil S. Brilakis
Journal of the American College of Cardiology | 2013
Michael Mooney; David Hildebrandt; David S. Feldman; Benjamin Sun; Dirck Rilla; Yale Wang; Ivan Chavez; M. Nicholas Burke; Timothy D. Henry
Journal of the American College of Cardiology | 2018
Angie S. Lobo; Yader Sandoval; M. Nicholas Burke; Ivan Chavez; Mario Gössl; Timothy D. Henry; Daniel Lips; Steven M. Bradley; Michael Mooney; Anil Poulose; Paul Sorajja; Jay H. Traverse; Yale Wang; Emmanouil S. Brilakis
Journal of the American College of Cardiology | 2018
Arslan Shaukat; Yader Sandoval; Larissa Stanberry; Ross Garberich; Amy McMeans; M. Nicholas Burke; Ivan Chavez; Mario Gössl; Timothy D. Henry; Daniel Lips; Michael Mooney; Anil Poulose; Paul Sorajja; Jay H. Traverse; Yale Wang; Steven M. Bradley; Emmanouil S. Brilakis
Journal of the American College of Cardiology | 2018
Ann Iverson; Larissa Stanberry; Ross Garberich; Amber Antos; Yader Sandoval; Peter Tajti; M. Nicholas Burke; Ivan Chavez; Mario Goessl; Timothy D. Henry; Daniel Lips; Michael Mooney; Anil Poulose; Paul Sorajja; Jay H. Traverse; Yale Wang; Steven M. Bradley; Emmanouil S. Brilakis